FDA Exempted Drugs From Banned factories, Raising Safety Concerns

‍ Updated ⁤July⁤ 03, 2024

The Food and Drug Management (FDA) granted exemptions to some of the most troubled foreign drugmakers in India over a dozen years, allowing factories banned from the U.S. market to ⁤continue⁣ shipping ⁢medications to the United States.

A ProPublica investigation found‍ that a secretive group inside the FDA exempted medications from import bans, ostensibly to prevent drug shortages.The agency ⁣dismissed warnings from its ⁤own inspectors about⁢ dangerous breaches in drug quality on⁤ factory floors.

The FDA allowed at least 150 drugs or their ingredients from banned factories found to have mold, foul‍ water, dirty‍ labs or fraudulent testing protocols into the United States. Nearly all ⁤came from ⁤factories in India.

The FDA did not regularly ‍test the drugs exempted ⁣from⁣ import ⁤bans to see if they‍ were safe or ⁤actively monitor reports‍ about potential harm among patients. The agency said it put protective measures ⁣in place, such ⁢as requiring third-party ⁣oversight of factories to ensure the exempted drugs were ‍safe.

Some of the exempted drugs were recalled ‍because of contaminants or other defects that⁤ could cause health problems. A⁣ ProPublica analysis identified more than⁤ 600⁤ complaints in the FDA’s files about the exempted drugs ⁢at three factories alone, each flagging concerns in the months ⁣or years after the medications⁢ were ⁣excluded from import bans. the reports⁣ cite ⁢about 70 hospitalizations and nine deaths.

Janet Woodcock,who for more than two decades led the FDA’s‍ Center for drug Evaluation and Research,said she didn’t see a need to inform the public about the drugs from banned factories because the agency believed they were safe and that such facts would ⁤create “some kind of frenzy” among consumers who might seek to change their prescriptions.⁤ She ⁤supported the exemptions to‍ deal with ⁣chronic drug shortages.

Decisions made by‍ the FDA decades ago gave rise to the‍ use of exemptions. In the 2000s, as the cost of brand-name⁤ drugs soared, the FDA approved hundreds⁤ of⁢ generic drug applications for foreign manufacturers that had been in ⁣trouble before.

The exempted drugs that have come to the United States include antibiotics, chemotherapy treatment, antidepressants, sedatives ‍and epilepsy medication.

In 2022,‍ FDA inspectors found dangerous breakdowns ⁢at a Sun Pharma plant in India, which produces dozens of generic drugs ⁣for Americans. The FDA placed the factory on an import⁤ ban but gave⁣ the manufacturer a special pass to ⁤continue sending more than a dozen drugs to Americans.

Sun Pharma said it would take steps to resolve the issues and ensure the regulator is wholly satisfied with the company’s remedial action. The company remains committed to being⁤ compliant⁤ and in supplying high-quality products to its customers⁤ and patients globally.

What’s next

The ‍FDA faces continued scrutiny over its ⁤oversight of foreign drug manufacturers and the use of exemptions ⁤for banned factories. Further investigations and policy changes ⁣may be implemented to‍ address safety concerns and ensure the quality of⁤ drugs imported into the United States.